Clinical Trial Update: Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating high-dose vitamin C for outcomes after cardiac surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-related Outcomes
• Reperfusion Injury

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Reperfusion Injury | Phase 4 | Status: COMPLETED | Results posted: 2020-10-19